International Conference on Cardiology and Cardiovascular Science

🩺Cardiogenic Shock & Mechanical Support – Expert Insights by Dr. Rohit Mody

The management of cardiogenic shock (CS) is undergoing a paradigm shift. At Cardiology Conference 2026, Dr. Rohit Mody will present a comprehensive update on the latest evidence surrounding mechanical circulatory support devices.

🚨 Why This Topic Matters

Cardiogenic shock complicating acute myocardial infarction remains one of the most lethal cardiovascular emergencies.

Mechanical support devices aim to:
⚡ Stabilize hemodynamics
🩺 Preserve organ function
🔄 Improve perfusion
📉 Reduce mortality

However, recent trials have reshaped clinical practice.

🔎 What Will Be Covered?

🏥 IABP

Still useful in selected complications and low-resource settings, though no longer recommended for routine AMI-CS.

🫁 VA-ECMO

Now largely limited to salvage therapy due to complication risk and lack of early survival benefit.

💡 Impella (Micro-Axial Flow Pump)

Supported by updated evidence showing mortality reduction in carefully selected STEMI-CS patients.

🔄 Advanced Combinations

ECPELLA and next-generation RV support devices offer tailored hemodynamic solutions.

🎯 Key Message

The future of cardiogenic shock treatment is precision-driven, phenotype-guided, and resource-aware — not routine device deployment.

👨‍⚕️ About the Speaker

Dr. Rohit Mody is a highly accomplished interventional cardiologist, academic leader, and healthcare entrepreneur 🌍 with a strong national and international footprint. He serves as CEO of the Mody Harvard Cardiac Institute & Research Centre and holds senior leadership roles across the Park Group and Clearmedi Group of Hospitals 🏥. With 99 peer-reviewed publications 📚 and 15 editorial board memberships 📝, he remains actively involved in guideline-oriented research and academic excellence. Dr. Mody is a regular faculty member at multinational cardiology conferences 🎤, delivering expert lectures and live case demonstrations worldwide. His work centers on complex coronary interventions ❤️‍🩹, innovation in cardiac care ⚙️, medical education 🎓, and expanding access to high-quality, equitable heart care across India and beyond.